CIK 0001048477
- Large accelerated filer
BIOMARIN PHARMACEUTICAL INC
Sign in to watch- Ticker
- BMRN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 680397820
- Phone
- +1 415-506-6700
- Business address
- 105 DIGITAL DRIVE, NOVATO, CA, 94949
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,466,459
- in 2 filings
Net −$1,466,459. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-05-27 | HOMBACH ROBERT J. Director | Grant or award | +4,300 | 16,210 | ||
| 2020-05-27 | HERON ELAINE J Director | Grant or award | +4,300 | 51,968 | ||
| 2020-05-27 | GREY MICHAEL G Director | Grant or award | +4,300 | 42,840 | ||
| 2020-05-27 | Dere Willard H Director | Grant or award | +4,300 | 17,720 | ||
| 2020-04-30 | FUCHS HENRY J President, Worldwide R&D | Grant or award | +339 | $62.59 | $21K | 102,995 |
| 2020-04-30 | Mueller Brian EVP, Chief Financial Officer | Grant or award | +323 | $62.59 | $20K | 25,104 |
| 2020-04-30 | Ajer Jeffrey Robert EVP, Chief Commercial Officer | Grant or award | +338 | $62.59 | $21K | 63,402 |
Page 36 of 36 · 707 trades